A Novel Use of Nanocrystalline Suspensions to Develop Sub-Microgram Dose Micro-Tablets
Developing solid oral drug products with good content uniformity (CU) at low doses is challenging; this challenge further aggravates when the tablet size decreases from a conventional tablet to a micro/mini-tablet (1.2 – 3mm diameter). To alleviate the CU issues, we present a novel use of…
Read More...
Read More...